National Health Investors stock falls to new 52-week low as guidance and dividend support sentiment

Published on 09/19/2026 at 16:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

National Health Investors stock touched a new 52-week low of USD 67.56 on September 18, 2026, even as the REIT keeps FY 2026 EPS guidance at 4.74 to 4.79. The shares offer an annualized dividend of USD 3.68 per share, implying a yield of about 5.4 percent at recent prices.

NHI, US6374321057, Illustration mit AI erstellt.

National Health Investors, Inc. stock (ISIN US6374321057) extended its recent weakness, trading down to a new 52-week low of USD 67.56 on September 18, 2026, on the New York Stock Exchange, compared with a prior close of USD 69.23, which represents a decline of about 2.4 percent in a single session according to MarketBeat data.MarketBeat On the same day, Investing.com reported that the shares touched USD 67.79, underscoring how the stock now trades well below its recent moving averages.Investing.com

Stock hits new 1-year low despite positive ratings

The break to a fresh 52-week low on September 18, 2026, came even though analyst sentiment toward National Health Investors stock remains broadly supportive, with a consensus rating of Moderate Buy and an average price target of USD 82.25, according to MarketBeat.MarketBeat That average target stands roughly USD 14.5 above the latest trade near USD 67.79, which implies an upside of more than 20 percent if the shares were to move back toward the consensus expectation.

At the technical level, MarketBeat notes that National Health Investors stock is now below both its 50-day moving average of USD 74.16 and its 200-day moving average of USD 76.96, a configuration that often signals a cautious phase for momentum-oriented investors.MarketBeat For long-term shareholders, however, the gap between the depressed price and the still-supportive analyst targets highlights the tension between macro headwinds in healthcare real estate and company-specific fundamentals.

Guidance and dividend underpin the investment case

Even as the stock trades at its lowest level in a year, National Health Investors has confirmed FY 2026 guidance with a projected earnings per share range of USD 4.74 to USD 4.79, according to MarketBeat’s coverage of the company’s outlook.MarketBeat At a share price around USD 67.79, the midpoint of that guidance implies a price-to-earnings multiple of slightly above 14 times FY 2026 earnings, which places the REIT in a moderate valuation range for the healthcare property segment.

Income remains a core attraction: MarketBeat reports that investors of record on September 30 will receive a quarterly dividend of USD 0.92 per share, corresponding to an annualized payout of USD 3.68 and a yield of approximately 5.4 percent at prevailing prices.MarketBeat For investors who prioritize stable cash distributions, that yield is an important counterbalance to near-term share price volatility.

Sector pressures shape risk perception

The broader healthcare real estate investment trust sector has faced headwinds over the past year, with Investing.com noting that National Health Investors stock has declined by about 13 percent over that period, reflecting concerns over lease coverage, interest-rate sensitivity and tenant operating performance.Investing.com Investing.com’s analysis also characterizes the stock as currently undervalued relative to its assessed fair value, while still emphasizing that sector-wide challenges have weighed on sentiment.

National Health Investors continues to own and finance a portfolio of senior housing and healthcare properties, a business model that ties long-term returns to demographic trends and the financial health of operators.MarketBeat Against the backdrop of its current share price, the confirmed FY 2026 EPS guidance and the established dividend policy suggest that management is aiming to steer the REIT through the sector’s adjustment phase without sacrificing its core income proposition.

Stock price and trading data

As of the last completed trading day on September 18, 2026, National Health Investors stock on the New York Stock Exchange traded in a range that saw an intraday low of USD 67.56 and a last trade reported around USD 67.79, with the prior close at USD 69.23 and turnover of 92,454 shares according to MarketBeat’s price snapshot.MarketBeat This places the stock at the bottom of its 52-week trading band, with the new low clearly below the 50-day and 200-day moving averages that had previously acted as medium-term reference points for many traders.